CFI-400945 |
CFI-400945 : ATP competitive inhibitor of PLK4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PLK4 |
|
|
ATP competitive
--
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
In radiometric assays, CFI-400945 inhibited 10/290 kinases >50%. IC50s for a subset of kinases were ...
In Cell Selectivity Assessment
Potency: EC50 - AURKA 510 nM, AURKB 102 nM, TRKA 84 nM, TRKB 88 nM, TEK 117 nM
Potency Assay Off-Target:
Negligible activity was detected against FGFRs and ROS.
Potency Cellular
In Vitro
PLK4
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? No
In Vivo Validations
CD1 nude mice
Dose: 2.4-20 mg/kg
Route of delivery:
Oral
Plasma half life:
3.7-4.2 hr
Organ of interest (O):
xenograft
Target engagement assay:
Indirect: inhibition of substrate phosphorylation in xenograft tissue
Reference: --
Chemical Information
| Molecular Formula | C33H34N4O3 |
| SMILEs | COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2 |
| InChI | InChI=1S/C33H34N4O3/c1-20-17-37(18-21(2)40-20)19-23-6-4-22(5-7-23)8-12-29-26-11-9-24(14-31(26)36-35-29)28-16-33(28)27-15-25(39-3)10-13-30(27)34-32(33)38/h4-15,20-21,28H,16-19H2,1-3H3,(H,34,38)(H,35,36)/b12-8+/t20-,21+,28-,33-/m0/s1 |
| Molecular weight | 534.26 Da |
| AlogP | 5.7285 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 74 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.